{{Drugbox
| verifiedrevid = 477317940
| IUPAC_name = 5,5-diprop-2-enyl-1,3-diazinane-2,4,6-trione
| image = Allobarbital.svg
| width = 120
| image2 = Allobarbital ball-and-stick animation.gif
| width2 = 160
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule IV
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Schedule III
| legal_DE = Anlage III
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 52-43-7
| ATC_prefix = N05
| ATC_suffix = CA21
| PubChem = 5842
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5635
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8NT43GG2HA
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02817
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 267719
<!--Chemical data-->
| C=10 | H=12
| N=2 | O=3
| molecular_weight = 208.214 g/mol
| smiles = O=C1NC(=O)NC(=O)C1(C\C=C)C\C=C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H12N2O3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4H,1-2,5-6H2,(H2,11,12,13,14,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FDQGNLOWMMVRQL-UHFFFAOYSA-N
| synonyms = 5,5-Diallylbarbituric acid, Allobarbital
}}
'''Allobarbital''', also known as '''allobarbitone''' and branded as '''Cibalgine''' or '''Dial-Ciba''' (in combination with [[ethyl carbamate]]), is a [[barbiturate]] derivative invented in 1912 by Ernst Preiswerk and Ernst Grether working for [[Ciba Specialty Chemicals|CIBA]]. It was used primarily as an [[anticonvulsant]]<ref>{{cite journal|last1=Chocholova L. |last2=Radil-Weiss |first2=T. |title=Effect of allobarbital on focal epilepsy in rats |journal=Physiologia Bohemoslovaca |year=1971 |volume=20 |issue=4 |pages=325–34 |pmid=4335127}}</ref> although it has now largely been replaced by newer drugs with improved safety profiles. Other uses for allobarbital included as an adjutant to boost the activity of [[analgesic]] drugs, and use in the treatment of [[insomnia]] and [[anxiety]]. 

Allobarbital was never particularly widely used compared to better known barbiturates such as [[phenobarbital]] and [[secobarbital]], although it saw more use in some European countries such as [[Bulgaria]] and [[Slovakia]],<ref>{{cite journal|last1=Getova |first1=D. |last2=Georgiev |first2=V. |title=GABA-ergic mechanisms in the anticonvulsive activity of newly synthesized barbiturates. I. Effects of barbiturates on the convulsive action of GABA-antagonists |journal=Acta Physiologica et Pharmacologica Bulgarica |year=1987 |volume=13 |issue=3 |pages=43–50 |pmid=3439474}}</ref> and is still used in for example Poland, but only as compound.<ref>{{cite web|title=APTECZKA BABUNI - KROPLE ŻOŁĄDKOWE KROPLE 20 G |trans_title=GRANDMA'S FIRST AID KIT - DROPS - STOMACH DROPS 20 G |website=Domzdrowia.pl |language=Polish |url=http://www.domzdrowia.pl/29439,apteczka-babuni-krople-zoladkowe-krople-20-g.html |archiveurl=https://web.archive.org/web/20071031195035/http://www.domzdrowia.pl/29439%2Capteczka-babuni-krople-zoladkowe-krople-20-g.html |archivedate=October 31, 2007 |accessdate=March 10, 2013 |deadurl=no }}</ref>

==References==
{{reflist}}


{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:GABAA receptor positive allosteric modulators]]